sulbactam has been researched along with Abdominal Abscess in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chandra, A; Desai, C; Dhar, P; Dharap, S; Goel, A; Gupta, R; Hardikar, JV; Kapoor, VK; Kochhar, P; Mathur, AK; Modi, P; Narwaria, M; Ramesh, H; Ramesh, MK; Sastry, RA; Schou, M; Shah, S; Somasundaram, S; Sreevathsa, MR; Sudheer, OV; Varshney, S; Virk, S | 1 |
Buhr, HJ; Frericks, B; Holmer, C; Lehmann, KS; Loddenkemper, C; Ritz, JP | 1 |
Powell, LL; Wilson, SE | 1 |
Chiu, DS; Phung, TL; Pipkin, CA; Tahan, SR | 1 |
Galandiuk, S; Lamos, J; Montgomery, W; Polk, HC; Young, S | 1 |
Bonomo, RA; Carias, LL; Rice, LB; Shlaes, DM | 1 |
Barefoot, L; Falagas, ME; Griffith, J; Ruthazar, R; Snydman, DR | 1 |
Azimi, PH; Collins, MD; Dajani, AS; Kaplan, SL; Kim, KS; King, DR; Kolokathis, A; Swanson, R | 1 |
1 review(s) available for sulbactam and Abdominal Abscess
Article | Year |
---|---|
The role of beta-lactam antimicrobials as single agents in treatment of intra-abdominal infection.
Topics: Abdomen; Abdominal Abscess; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Clavulanic Acids; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Surgical Wound Infection; Ticarcillin | 2000 |
2 trial(s) available for sulbactam and Abdominal Abscess
Article | Year |
---|---|
Cefoperazone-sulbactam for treatment of intra-abdominal infections: results from a randomized, parallel group study in India.
Topics: Abdominal Abscess; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefoperazone; Ceftazidime; Child; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; India; Male; Metronidazole; Middle Aged; Peritonitis; Sulbactam; Treatment Failure; Treatment Outcome | 2008 |
Comparison of ampicillin/sulbactam plus aminoglycoside vs. ampicillin plus clindamycin plus aminoglycoside in the treatment of intraabdominal infections in children. The Multicenter Group.
Topics: Abdominal Abscess; Aminoglycosides; Ampicillin; Bacterial Infections; Child; Child, Preschool; Clindamycin; Drug Therapy, Combination; Female; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Male; Prospective Studies; Species Specificity; Sulbactam; Tobramycin; Treatment Outcome | 1998 |
5 other study(ies) available for sulbactam and Abdominal Abscess
Article | Year |
---|---|
Preoperative CT staging in sigmoid diverticulitis--does it correlate with intraoperative and histological findings?
Topics: Abdominal Abscess; Ampicillin; Anti-Bacterial Agents; Cellulitis; Colon, Sigmoid; Diverticulitis, Colonic; Female; Humans; Infusions, Intravenous; Intestinal Perforation; Male; Middle Aged; Peritonitis; Preoperative Care; Prospective Studies; Sensitivity and Specificity; Sigmoid Diseases; Statistics as Topic; Sulbactam; Tomography, X-Ray Computed | 2010 |
Beta-lactam antibiotic-induced pseudoporphyria.
Topics: Abdominal Abscess; Ampicillin; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Biopsy; Fallopian Tube Diseases; Female; Forehead; Humans; Kidney Failure, Chronic; Leukocyte Count; Lupus Erythematosus, Systemic; Middle Aged; Ovarian Diseases; Pruritus; Renal Dialysis; Sickle Cell Trait; Skin; Skin Diseases, Vesiculobullous; Sulbactam; Thrombocytopenia | 2004 |
Antibiotic penetration of experimental intra-abdominal abscesses.
Topics: Abdominal Abscess; Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Cefmetazole; Cefoxitin; Ceftriaxone; Clindamycin; Drug Evaluation, Preclinical; Drug Therapy, Combination; Escherichia coli Infections; Hydrogen-Ion Concentration; Male; Mice; Microbial Sensitivity Tests; Spectinomycin; Sulbactam | 1995 |
Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy.
Topics: Abdominal Abscess; Amino Acid Sequence; Ampicillin; Animals; Base Sequence; beta-Lactamase Inhibitors; beta-Lactamases; Ceftazidime; Cephalosporin Resistance; Cephalosporins; DNA, Bacterial; Drug Therapy, Combination; Escherichia coli; Klebsiella Infections; Klebsiella pneumoniae; Molecular Biology; Molecular Sequence Data; Penicillanic Acid; Penicillin Resistance; Piperacillin; Piperacillin, Tazobactam Drug Combination; R Factors; Rats; Sulbactam | 1996 |
Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections.
Topics: Abdominal Abscess; Adult; Age Factors; Aged; Ampicillin; Anti-Bacterial Agents; Cefotetan; Cefoxitin; Cephamycins; Drug Resistance, Microbial; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Matched-Pair Analysis; Middle Aged; Multivariate Analysis; Penicillins; Pseudomonas Infections; Retrospective Studies; Risk Factors; Sex; Skin Diseases, Bacterial; Soft Tissue Infections; Sulbactam; Treatment Outcome | 1996 |